Tirzepatide, un agonista dual de receptores GIP/GLP-1 aprobado por la FDA, reduce el apetito y retrasa el vaciamiento gstrico, pero requiere ajustes nutricionales especficos
Continue to take as directed and your provider will titrate your dose as needed to promote optimal weight loss tailored to your clinical needs
The FDA labels for both semaglutide and tirzepatide address lactation, but the language reveals more about the state of research than the state of risk
Doing so allows the drug to come to room temperature, which may make the injection more comfortable
Finally, thanks to the vision of David Ricks, [Eli Lillys chief executive], and Mike Doustdar, [president and CEO at Novo Nordisk], and the other people on our team, they were able to figure out a way to align the interests of their shareholders with the health of the American public, Kennedy said